FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure ...
FDA meeting to choose flu vaccine composition canceled without explanation
A March meeting of outside advisers to the United States Food and Drug Administration to discuss the composition of flu ...
FDA Cancels Critical Flu Vaccine Meeting With No Explanation
The FDA canceled a critical annual flu vaccine planning meeting without explanation days after Robert F. Kennedy Jr. took ...
US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
FDA Drags Heels on Vaccine Plans
The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Morningstar3d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...
FDA cancels meeting to select flu strains for next season's shots
A Food and Drug Administration vaccine advisory committee meeting scheduled for March to select the strains to be included in ...
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
manilatimes3h
VANTAGE FILES FDA DRUG MASTER FILE FOR VYCERIN™ API GLYCERIN, USP DESIGNED SPECIFICALLY TO MEET PHARMACEUTICAL FORMULATION NEEDS
Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and Drug Administration (FDA).
manilatimes3d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
DM is an immune-mediated myopathy characterized by chronic inflammation of the skin and muscles, progressive muscle weakness, and potential involvement of internal organs. The role of complement ...